Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compositions and methods for promoting nerve regeneration

a nerve regeneration and composition technology, applied in the field of compositions and methods for promoting nerve regeneration, can solve the problem of slow rate of axonal elongation (3-4 mm/day)

Inactive Publication Date: 2005-10-13
OREGON HEALTH & SCI UNIV
View PDF18 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text describes the discovery of a mechanism for promoting nerve cell growth and regeneration through the use of certain compounds, such as geldanamycin and FK506, that bind to specific proteins in the body. These compounds can be administered as pharmaceutical compositions to treat nerve injuries and promote nerve cell growth. The patent also describes methods for identifying and testing these compounds for their ability to stimulate nerve cell growth. Overall, the patent provides a technical solution for promoting nerve regeneration and has potential applications in the field of neurology and regenerative medicine.

Problems solved by technology

However, the rate of axonal elongation (3-4 mm / day) is slow.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions and methods for promoting nerve regeneration
  • Compositions and methods for promoting nerve regeneration
  • Compositions and methods for promoting nerve regeneration

Examples

Experimental program
Comparison scheme
Effect test

examples

FK506 and Geldanamycin Promote Nerve Regeneration by a Common Mechanism

Materials and Methods

[0123] Cell cultures. SH-SY5Y human neuroblastoma cells were maintained in DMEM medium (GIBCO) supplemented with 10% fetal calf serum (SIGMA), 50 IU / mL penicillin, and 50 mg / mL streptomycin (GIBCO) at 37° C. in 7% CO2. Cells were plated in six-well plates at 1×106 cells / well and treated with 0.4 mM aphidicolin (SIGMA). At five days, cells were washed, treated with nerve growth factor (NGF) (Boehringer Mannheim, Indianapolis, Ind.) at 10 ng / mL (to induce process outgrowth) in the presence or absence of FK506 (1 and 10 nM) (Calbiochem-Novabiochem Int'l., La Jolla,. CA) and / or geldanamycin (0.1, 1, and 10 nM) (Calbiochem-Novabiochem, La Jolla, Calif.). Media was changed at 96 hours and replaced with fresh media with the compounds (NGF plus FK506 and / or geldanamycin) for an additional 72 hours (total time, 168 hours). The top 50% of axonal lengths were selected for statistical analysis. All e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightsaaaaaaaaaa
total timeaaaaaaaaaa
total timeaaaaaaaaaa
Login to View More

Abstract

FK506 and geldanamycin promote nerve regeneration by a common mechanism that involves the binding of these compounds to polypeptide components of steroid receptor complexes other than the steroid hormone binding portion of the complex (FKBP52 and hsp90, respectively). These and other agents cause hsp90 dissociation from steroid receptor complexes or block association of hsp90 with steroid receptor complexes.

Description

BACKGROUND OF THE INVENTION [0001] Following traumatic or mechanically induced axonal degeneration in the peripheral nervous system, axonal regeneration ensues, resulting in functional recovery. However, the rate of axonal elongation (3-4 mm / day) is slow. Consequently, recovery is measured in weeks or months, depending upon the distance between the site of injury and the target tissue. Therapies that speed regeneration over long distances would be highly beneficial to patients and would significantly reduce health care costs. [0002] The immunosuppressant drug FK506 (USAN tacrolimus; Prograf®) speeds functional recovery and axonal regeneration in the rat in a dose-dependent manner following a sciatic nerve crush lesion (Gold et al., J. Neurosci. 15:7505-7516, 1995; Gold ec al., Restor. Neurol. Neurosci. 6:287-296, 1994). FK506 was shown to stimulate neuritic outgrowth in a rat pheochromocytoma cell line in a concentration-dependent manner (Lyons et al., Proc. Natl. Acad. Sci. USA 91:...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/395A61K31/4745A61K38/18A61K45/00A61K39/395A61K45/06A61P25/00A61P43/00
CPCA61K31/395A61K31/4745A61K45/06G01N33/743G01N33/5058G01N2500/02Y10T436/14A61K38/1883A61K2300/00A61P25/00A61P43/00
Inventor GOLD, BRUCE G.
Owner OREGON HEALTH & SCI UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com